Pacira BioSciences
PCRX
PCRX
260 hedge funds and large institutions have $1.65B invested in Pacira BioSciences in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 92 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 260 → 260 (0)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
5% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 92
Holders
260
Holding in Top 10
5
Calls
$12.8M
Puts
$5.96M
Top Buyers
| 1 | +$35.1M | |
| 2 | +$30.7M | |
| 3 | +$20.5M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$9.62M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.4M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$19.4M | |
| 3 | -$19.1M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$14.7M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$9.37M |